• Users Online: 8165
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Reader Login
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Most cited articles *

 
 
  Archives   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
REVIEW ARTICLES
Itraconazole: What clinicians should know?
Piet De Doncker, Sushil Pande, Ute Richarz, Nishant Garodia
January-June 2017, 3(1):4-10
DOI:10.4103/ijdd.ijdd_20_17  
  24 24,854 1,854
ORIGINAL ARTICLES
Tuberculin purified protein derivative immunotherapy in the treatment of viral warts
Ajay Nimbalkar, Sushil Pande, Ramesh Sharma, Milind Borkar
January-June 2016, 2(1):19-23
DOI:10.4103/2455-3972.184103  
  19 19,177 618
EDITORIAL
Clinical failure of antifungal therapy of dermatophytoses: Recurrence, resistance, and remedy
Ragunatha Shivanna, Arun C Inamadar
January-June 2017, 3(1):1-3
DOI:10.4103/ijdd.ijdd_13_17  
  9 13,772 1,054
ORIGINAL ARTICLES
Effect of measles mumps rubella vaccine in treatment of common warts
Anuja Dhope, Bhushan Madke, Adarsh Lata Singh
January-June 2017, 3(1):14-19
DOI:10.4103/ijdd.ijdd_1_17  
  9 18,716 518
REVIEW ARTICLE
Apremilast: A dermatologic perspective
Aditya Kumar Bubna
July-December 2016, 2(2):75-82
DOI:10.4103/2455-3972.196166  
  7 25,059 1,780
BRIEF REPORT
Successful use of oral acitretin in oral lichen planus
Ajay Deshpande
January-June 2017, 3(1):24-27
DOI:10.4103/ijdd.ijdd_9_17  
  6 12,685 221
EDITORIAL
Steroid containing fixed drug combinations banned by government of India: A big step towards dermatologic drug safety
Sushil Pande
January-June 2016, 2(1):1-2
DOI:10.4103/2455-3972.184102  
  6 14,198 377
REVIEW ARTICLE
Bilastine: A novel antihistamine
Jeet Gandhi, Kiran Godse, Gauri Godse
January-June 2018, 4(1):3-6
DOI:10.4103/ijdd.ijdd_12_18  
  6 30,952 1,665
EDITORIAL
Topical sirolimus in the treatment of facial angiofibromas
Resham Vasani
July-December 2018, 4(2):49-51
DOI:10.4103/ijdd.ijdd_34_18  
  5 8,730 250
Tranexamic acid in melasma: Why and how?
Shuken Dashore, Katyain Mishra
July-December 2017, 3(2):61-63
DOI:10.4103/ijdd.ijdd_37_17  
  5 65,392 1,299
LETTERS TO EDITOR
Azathioprine-induced alopecia as an early clinical marker of its myelotoxicity
Anil B Bhokare
January-June 2017, 3(1):40-41
DOI:10.4103/ijdd.ijdd_4_17  
  5 42,060 169
ORIGINAL ARTICLES
A study of clinical patterns and causative agents of adverse cutaneous drug reactions
Nilesh Mahatme, R Narasimharao
January-June 2016, 2(1):13-18
DOI:10.4103/2455-3972.184088  
  5 5,677 281
ALTERNATIVE MEDICINE
Homeopathic management of warts
Piyush Mahendra Oza
January-June 2016, 2(1):45-47
DOI:10.4103/2455-3972.184085  
  4 217,280 917
CASE REPORTS
Generalized bullous fixed drug reaction: A close similarity to stevens–johnson syndrome
Bhagyashri Daulatabadkar, Sushil Pande, Milind Borkar
January-June 2017, 3(1):28-31
DOI:10.4103/ijdd.ijdd_11_17  
  4 14,205 358
EDITORIAL
Second-line anti-leprosy drugs: Indian experience
Vivek V Pai
January-June 2020, 6(1):1-4
DOI:10.4103/ijdd.ijdd_66_19  
  4 15,822 506
ORIGINAL ARTICLES
Use of over-the-counter topical medications in dermatophytosis: A cross-sectional, single-center, pilot study from a tertiary care hospital
Rajeshwari Dabas, Manasa Shettisara Janney, Radhakrishnan Subramaniyan, Sandeep Arora, V Sandeep Lal, Navya Donaparthi
January-June 2018, 4(1):13-17
DOI:10.4103/ijdd.ijdd_5_18  
  4 7,671 301
Clinical spectrum of cutaneous adverse drug reactions
Ankita Agrawal, Smita Ghate, Abhishek Kumar Gupta, Rachita Dhurat
July-December 2018, 4(2):61-66
DOI:10.4103/ijdd.ijdd_14_18  
  4 7,357 343
BRIEF REPORT
Successful use of cyclosporine in the treatment of toxic epidermal necrolysis: A case series
Vikrant Saoji, Shilpa Hazare, Sanjiv Choudhary
January-June 2016, 2(1):24-27
DOI:10.4103/2455-3972.184089  
  3 9,053 237
CASE REPORTS
An alternative hepatosafe treatment in leprosy
Anuradha Ashok Bhide, Usha N Khemani, Ratnakar R Kamath, Varsha Vaidyanathan, Abhishek P Ponathil, Mahendra M Kura
January-June 2016, 2(1):33-36
DOI:10.4103/2455-3972.184086  
  3 13,707 469
Topical steroid-dependent face: Response to xylometazoline topical
Sushil Kakkar, Prafulla K Sharma
July-December 2017, 3(2):87-89
DOI:10.4103/ijdd.ijdd_6_16  
  3 17,420 284
EDITORIAL
Biologics in psoriasis: Indian experience
Shrichand G Parasramani, Jisha Pillai
January-June 2019, 5(1):1-5
DOI:10.4103/ijdd.ijdd_33_19  
  3 17,846 791
ORIGINAL ARTICLES
Real-life efficacy and safety of secukinumab: A single-center, retrospective observational study with 52-week follow-up
Shekhar Neema, S Radhakrishnan, Sehdev Singh, Biju Vasudevan, Manas Chatterjee
January-June 2019, 5(1):14-18
DOI:10.4103/ijdd.ijdd_37_18  
  3 4,660 151
Intralesional bleomycin in the treatment of common warts
Mahesh Unni, Vaibhav Tapare
July-December 2017, 3(2):73-76
DOI:10.4103/ijdd.ijdd_26_17  
  3 13,679 309
A clinical study of severe cutaneous adverse drug reactions and role of corticosteroids in their management
Rohini Sharma, Naina Dogra, Devraj Dogra
January-June 2017, 3(1):20-23
DOI:10.4103/ijdd.ijdd_22_16  
  3 5,487 223
MANAGING A SIDE EFFECT
Oral retinoid-induced cheilitis
Bhushan Madke, Hiral Shah, Adarsh Lata Singh, Meenaz Khoja, Poonam Kabra
January-June 2016, 2(1):50-53
DOI:10.4103/2455-3972.184104  
  2 14,301 281
* Source: CrossRef